Analyst Ratings for Genmab A/S (GMAB)
GMAB Rating Summary
GMAB Price Target Summary
- Highest: $48.00 (Truist Securities)
- Lowest: $32.00 (TD Cowen)
- Average: $39.93
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$39.93 (+47.6%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 66%
Avg. $ Target:
$39.93 (+47.6%)
* Over Last 12-Mos
Rating Score: 6.2 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | Wells Fargo | Eva Fortea Verdejo | New Coverage | Overweight (N/A) |
40.00 (N/A) |
29.44 (27.06) |
-8.08% | Details |
| 2/17/2026 | Jefferies | Benjamin Jackson | New Coverage | Buy (N/A) |
41.50 (N/A) |
29.59 (27.06) |
-8.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
